(PharmaNewsWire.Com, September 11, 2017 ) The Europe Hemodynamic Monitoring Devices market has been estimated at USD 251.10 Million in 2016 and is projected to reach USD 304.04 Million by 2021, at a CAGR of 3.90% during the forecast period from 2016 to 2021. The hemodynamic monitoring system is primarily used for clinical inspection of cardiovascular health, longevity and quality of life of patients undergoing and recovering from cardiac surgery. Physicians perform hemodynamic monitoring using pulmonary artery catheter that helps administer and maintain adequate perfusion pressure. This helps to identify these risk factors and improve clinical status.
The market for Hemodynamic Monitoring Devices is mainly driven due to most of the geriatric population situated in this region, which suffers from hypertension & diabetes and requires round the clock monitoring. Also, the market is growing continuously due to the technological shift from invasive monitoring systems to minimally and non-invasive monitoring systems. But, the market growth can be restrained due to high price of devices and treatment costs.
Europe market for Hemodynamic Monitoring devices is segmented based on Product Type and Monitoring Type. By Product, the market is further sub-segmented into Systems and Disposables. By Monitoring type, the market is further sub-segmented into Invasive, Minimally invasive, Non-invasive. By end-users, the market is further sub-segmented into Hospitals, Cath labs, Home and Ambulatory Care. Based on products, disposables segment is estimated to account for the largest share. Based on types, the invasive monitoring systems segment is estimated to account for the largest share. Based on end users, hospitals segment is estimated to account for the largest share. All of these three segments are projected to grow at the highest CAGR during the forecast period.
Geographically, Europe market for Hemodynamic Monitoring Devices is segmented into U.K., Germany, Spain, France and Italy. Europe is the second biggest market in terms of market share across the globe. Increasing competition and market maturity in this region has reduced scope of expansion.
Edwards Lifesciences Corporation, PULSION Medical Systems SE, LiDCO Group plc., Cheetah Medical Inc., Deltex Medical Group plc., Hemo Sapiens, Inc., ICU Medical, Inc., Osypka Medical GmbH, Schwarzer Cardiotek GmbH, and Tensys Medical, Inc. are the major players of Europe Hemodynamic Monitoring Devices market.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
